Mesenchymal stem cell expressing TRAIL as targeted therapy against sensitised tumour
Tapping into the ability of engineered mesenchymal stem cells (MSCs) to mobilise into the tumour has expanded the scope of cancer treatment. Engineered MSCs expressing tumour necrosis factor (TNF)-related apoptosis inducing ligand (MSC-TRAIL) could serve as a platform for an efficient and targeted f...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
MDPI
2018
|
| On-line přístup: | http://psasir.upm.edu.my/id/eprint/74939/1/ijms-19-02188.pdf |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|